{
  "nctId": "NCT06901869",
  "briefTitle": "Physical Activity in Persons With Parkinson's Disease",
  "officialTitle": "ActivPARK - Physical Activity in Persons With Parkinson's Disease- Pilot Study",
  "protocolDocument": {
    "nctId": "NCT06901869",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2025-02-05",
    "uploadDate": "2025-03-06T03:18",
    "size": 876935,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT06901869/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 50,
    "enrollmentType": "ESTIMATED"
  },
  "timeline": {
    "startDate": "2025-03-25",
    "completionDate": "2026-12",
    "primaryCompletionDate": "2026-12",
    "firstSubmitDate": "2025-03-17",
    "firstPostDate": "2025-03-30"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Diagnosed with Parkinson's disease\n* Mild to severe disease severity ( Hoehn \\& Yahr 1-4).\n\nExclusion Criteria:\n\n* None",
    "healthyVolunteers": false,
    "sex": "ALL",
    "stdAges": [
      "CHILD",
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Feasibility of the assessment battery - length of the clinical examination and questionnaires",
        "description": "The pilot/feasibility study aims to evaluate feasibility of the assessment battery measured the time it takes to complete the examination and questionnaires.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Feasibility of the assessment battery - perception of the clinical examination",
        "description": "Feasibility of the assessment battery will also be evaluated through semi-structured questions regarding fatique, concentration, pain/discomfort to the participants after the clinical examination.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Feasibility of the assessment battery -Compliance to questionnaires sent via REDCap",
        "description": "Compliance will be measured with percentages of completed questionnaires in REDCap.",
        "timeFrame": "Baselline"
      },
      {
        "measure": "Feasibility of the assessment battery - Suitability of the primary outcome",
        "description": "Suitability of the accelerometers in the home environment as the primary outcome for the targeted patient group will be assessed by the percentage of participants that are able to wear the accelerometer for at least 4 days days and render valid data.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Physical activity levels",
        "description": "The ActiGraph accelerometer (GT3X+, ActiGraph, Pensacola, FL, US) will be used to measure absolute and relative time spent in sedentary behavior, low intensity physical activity (LIPA) and moderate to vigorous intensity physical activity (MVPA), by total time in bouts.",
        "timeFrame": "Baseline"
      }
    ],
    "secondary": [
      {
        "measure": "Physical activity - self rated",
        "description": "Fr√§ndin Grimby scale, ranging from 1 to 6, higher score=better.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Disease severity, Parkinson symptoms",
        "description": "Movement Disorders Society- Unified Parkinson's Disease Rating Scale (MDS- UPDRS) parts 1 to 4.\n\nHigher scores = worse/more symptoms",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Gait",
        "description": "Gait speed in m/s measured with the 10 meter walking test or through gait analysis.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Balance performance",
        "description": "Assessed with the Mini-BESTest. Mini-Balance Evaluation Systems Test a rating scale for dynamic balance incorporating 14 different balance and gait items that were assessed by a physical therapist on a scale from 0-2. Maximum points 28. 0-28 points with higher scores indicating better balance control",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Anxiety and depression",
        "description": "Assessed with Hospital Anxiety and Depression Scale (HADS), 0-24 on the depression and anxiety part respectively. Lower score=better",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Cognitive performance",
        "description": "Assessed with the Montreal Cognitive Assessment (MoCA), 0-25, higher score = better",
        "timeFrame": "Baseline and 3 year follow-up"
      },
      {
        "measure": "Self assessed cognitive function",
        "description": "Assessed with Executive function questionnaire (DEX), 20 items scored 1 to 4, max 80, more scores= worse.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Non-Motor Symptoms",
        "description": "Non-Motor Symptoms Questionnaire (NMSQ), 30 questions with yes/no answer. More yes answers = more non-motor symptoms",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Walking ability- self assessed",
        "description": "WALK-12G questionnaire, 0 and 42 points, with higher scores reflecting greater perceived walking difficulties (higher=worse)",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Freezing of gait - self-assessed",
        "description": "Freezing of gait questionnaire (FOGQsa), 6 questions/items, scored 1 to 5 (higher=worse)",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Balance confidence",
        "description": "Activities specific balance confidence (ABC scale), 16 items which is scored 1 to 10 and then divided by 16. 0-100%, higher % = better",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Motivation",
        "description": "Behavioural Regulation in Exercise Questionnaire (BREQ 4), 28 items score 1 to 7 and divided into subcomponents: Amotivation, External regulation, Introjected avoidance, Introjected approach, Identified regulation, Integrated regulation, Intrinsic regulation",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Fatigue",
        "description": "Parkinson's Fatigue Scale (PFS-16), 16 items scored 1 to 5 from strongly disagree to strongly agree . more points/score= worse.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Disability",
        "description": "World health organization (WHO) disability assessment schedule (Whodas 2.0), 12 self-assessed questions (12 to 60) more points=worse",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Self-efficacy",
        "description": "Self-efficacy of exercise/PA (ESES), 10 questions, scored 1-4. higher=better",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Sleep",
        "description": "Scales for Outcomes in Parkinson's disease - Sleep (SCOPA-SLEEP), 4 parts, A-2 questions, B-5 questions , C-1 question and D- 6 questions. Higher= worse",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Self rated pain",
        "description": "Assessed with visual analog scale, VAS from 0 to 100",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Health related quality of life",
        "description": "Parkinson's Disease Questionnaire (PDQ39). The Parkinson's Disease Questionnaire (PDQ-39) assesses how often people with Parkinson's experience difficulties across 8 dimensions of daily living (mobility, activities of daily living, emotional well-being, stigma, social support, cognitions, communications and bodily discomfort). The sum score is as a percentage score ranging between 0 and 100. Higher is better",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Wellbeing",
        "description": "The WHO- Five Well-Being Index (WHO-5), 5 questions ranging from 0 to 5, 0-25, higher=better",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Nutrition",
        "description": "Mini Nutritional Assessment, max 14. higher = better",
        "timeFrame": "Baseline"
      }
    ],
    "other": [
      {
        "measure": "Working och long-term memory",
        "description": "Rey-Auditory Verbal Learning Test (RAVLT), higher= better",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Parkinson related pain",
        "description": "Assessed with the Kings Parkinsons Pain Scale (KPPS), max 168, higher= more pain",
        "timeFrame": "Baseline"
      }
    ]
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 5,
      "secondaryCount": 20,
      "otherCount": 2,
      "totalCount": 27
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:43.224Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}